13F Holdings
中文EN

LUNG Pulmonx Corp

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1127537 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.2%
TTM net income YoY25.0%
TTM EPS YoY28.4%
Revenue 3-yr CAGR11.1%
Net income 3-yr CAGR—

Margins

Gross margin77.4%
Operating margin-44.4%
Net margin-47.9%
FCF margin-28.8%
EBITDA margin-43.4%

Returns

ROE-90.3%
ROA-34.2%
ROIC (approx.)-155.9%
Asset turnover0.71x

Leverage & solvency

Liabilities / assets69.0%
Debt / equity1.11x
Current ratio4.05x
Interest coverage-9.39x

Cash quality & payout

Operating cash flow / net income0.60x
Accruals ratio-13.7%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$90.50M$83.79M$68.67M$53.66M$48.42M
Cost of revenue$23.36M$21.79M$17.92M$13.80M$12.79M
Gross profit$67.14M$62.00M$50.75M$39.87M$35.63M
R&D expense$19.49M$17.57M$18.08M$15.40M$13.06M
SG&A expense$101.31M$102.14M$94.61M$83.11M$69.87M
Operating income-$53.66M-$57.70M-$61.94M-$58.64M-$47.30M
Interest expense$3.15M$3.51M$3.23M$1.07M$829,000
Pretax income-$53.38M-$55.89M-$60.27M-$58.57M-$48.32M
Income tax$626,000$500,000$571,000$353,000$343,000
Net income-$54.00M-$56.39M-$60.84M-$58.92M-$48.66M
EBITDA-$52.56M-$56.60M-$60.53M-$57.24M-$46.60M
EPS (basic)-1.33-1.44-1.60-1.59-1.35
EPS (diluted)-1.33-1.44-1.60-1.59-1.35
Weighted avg. shares (diluted)40.69M39.11M37.97M37.10M36.13M
Balance sheet
Cash & equivalents$69.75M$71.16M$83.78M$101.97M$148.71M
Short-term investments———$39.40M$31.56M
Receivables$12.07M$13.12M$12.11M$8.68M$6.56M
Inventory$15.85M$16.91M$16.74M$14.56M$16.29M
Current assets$101.68M$136.25M$150.42M$168.95M$208.00M
PP&E, net$2.22M$2.91M$4.03M$4.69M$4.81M
Goodwill$2.33M$2.33M$2.33M$2.33M$2.33M
Intangibles—$0$31,000$154,000$277,000
Total assets$129.29M$162.85M$177.78M$193.68M$235.17M
Current liabilities$20.06M$24.44M$23.16M$18.49M$17.55M
Short-term debt$106,000$3.18M$2.15M$90,000$91,000
Long-term debt$36.99M$34.00M$35.09M$17.23M$17.32M
Total debt$37.09M$37.18M$37.24M$17.32M$17.41M
Total liabilities$75.17M$77.04M$59.47M$39.67M$41.93M
Shareholders' equity$54.12M$85.81M$118.31M$154.01M$193.24M
Net debt-$32.66M-$33.98M-$46.54M-$84.64M-$131.30M
Shares outstanding41.67M39.79M38.52M37.56M36.93M
Cash flow statement
Operating cash flow-$32.38M-$31.54M-$37.61M-$45.08M-$41.39M
Capital expenditure$452,000$1.45M$807,000$1.32M$3.67M
Free cash flow-$32.83M-$32.98M-$38.42M-$46.40M-$45.06M
Investing cash flow$30.48M$17.48M-$2.01M-$4.22M-$46.26M
Financing cash flow$833,000$1.36M$21.40M$2.42M$4.46M
Depreciation & amortization$1.10M$1.10M$1.40M$1.40M$700,000
Stock-based compensation$21.23M$22.95M$22.10M$16.45M$10.53M
Share buybacks——$0$27,000$26,000

Free plan shows the latest 5 periods; Pro shows all 8 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.